Results 1 to 10 of about 13,521,848 (335)

Interleukin (IL-6) Immunotherapy [PDF]

open access: yesCold Spring Harbor Perspectives in Biology, 2017
Interleukin 6 (IL-6) is a prototypical cytokine for maintaining homeostasis. When homeostasis is disrupted by infections or tissue injuries, IL-6 is produced immediately and contributes to host defense against such emergent stress through activation of acute-phase and immune responses.
Toshio, Tanaka   +2 more
openaire   +3 more sources

The role of IL-6 and IL-6 blockade in COVID-19 [PDF]

open access: yesExpert Review of Clinical Immunology, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a dysregulated hyperinflammatory response.Authors review evidence on IL-6 and IL-6 blockade in coronavirus disease 2019 (COVID-19) and discuss the pathophysiological and prognostic roles of this cytokine and the clinical impact of pharmacological blockade of IL-6 .
Nicola Potere   +7 more
openaire   +6 more sources

A Potential Role of IL-6/IL-6R in the Development and Management of Colon Cancer

open access: yesMembranes, 2021
Colorectal cancer (CRC) is the third most frequent cancer worldwide and the second greatest cause of cancer deaths. About 75% of all CRCs are sporadic cancers and arise following somatic mutations, while about 10% are hereditary cancers caused by ...
Mimmo Turano   +4 more
doaj   +1 more source

Subcutaneous IL-6 Inhibitor Sarilumab vs. Standard Care in Hospitalized Patients With Moderate-To-Severe COVID-19: An Open Label Randomized Clinical Trial

open access: yesFrontiers in Medicine, 2022
BackgroundThe use of IL-6 blockers in COVID-19 hospitalized patients has been associated with a reduction in mortality compared to standard care. However, many uncertainties remain pertaining to optimal intervention time, administration schedule, and ...
Rosario García-Vicuña   +15 more
doaj   +1 more source

Treatment with Tocilizumab in Adult Patients with Moderate to Critical COVID‐19 Pneumonia: A Single‐Center Retrospective Study

open access: yesInternational Journal of Infectious Diseases, 2022
Objectives: This study aimed to assess if tocilizumab (TCZ) timing is associated with improved survival. Material and methods: Data obtained from adult patients with moderate/severe/critical COVID-19 and treated with TCZ, who were admitted to the ...
Amanda Radulescu   +2 more
doaj   +1 more source

Exploring the Predictive Value of Inflammatory Biomarkers in COVID-19 Patients: A Prospective Cohort Study in Malang, Indonesia

open access: yesIndonesian Journal of Chemistry, 2023
The objective of this study was to assess the predictive value of inflammatory biomarkers in COVID-19 patients, namely the CRP/albumin ratio (CAR), interleukin 6 (IL-6), IL-6/lymphocyte ratio (IL-6/LY), and neutrophil/lymphocyte ratio (NLR).
Agustin Iskandar   +6 more
doaj   +1 more source

Interleukin-6 mediates delirium-like phenotypes in a murine model of urinary tract infection

open access: yesJournal of Neuroinflammation, 2021
Background Urinary tract infection (UTI) is frequently implicated as a precipitant of delirium, which refers to an acute confusional state that is associated with high mortality, increased length of stay, and long-term cognitive decline. The pathogenesis
Mohammad Harun Rashid   +8 more
doaj   +1 more source

Evaluation of serum levels of interleukins 6, 8, 17 and 22 in acne vulgaris: A cross-sectional study

open access: yesIndian Journal of Dermatology, 2023
Background: Acne vulgaris (AV) is a chronic, multifactorial, inflammatory skin disease, and it is now becoming increasingly clear that the inflammatory pathway is involved at a very early in the pathogenesis of acne.
Sweta Singh   +2 more
doaj   +1 more source

Serum IL–1β, IL–2, IL–6, and IL–8 levels in schizophrenia subtypes

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: The cytokines are considered to be an important topic in immunological studies of schizophrenia. In this clinical study IL-1β, IL-2, IL-6, and IL-8 levels were compared among schizophrenia subtypes and a control group.
Murat Kuloglu   +4 more
doaj   +1 more source

The Role of Interleukin-6, and IL-12+p40 in the Development of Ischemic Heart Disease

open access: yesKufa Journal for Nursing Sciences, 2023
Background: Because low-grade inflammation may play a role in the pathogenesis of coronary heart disease, and pro-inflammatory cytokines govern inflammatory cascades leading to atherosclerosis, and then to ischemic heart disease.
Dina A. A. Al-Roubaey   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy